
Ubigene gene knockout cell lines mediated by optimized CRISPR-Cas9 technology provide reliable in vitro models for investigating gene function, signaling pathways, disease mechanisms, and therapeutic targets.
RB1CC1 (RB1 inducible coiled-coil 1) encodes a coiled-coil protein that interacts with signaling pathways regulating cell growth, proliferation, apoptosis, autophagy, and cell migration. It also enhances expression of the RB1 gene in cancer cells. RB1CC1 therefore integrates multiple cellular regulatory processes and has been characterized as a tumor suppressor involved in control of cell growth and survival.
A human pancreatic cancer model, MIA PaCa-2 originated from a primary pancreatic carcinoma of a 65-year-old male. The cells are classified as a human pancreatic cancer cell line and exhibit epithelial characteristics. MIA PaCa-2 has been extensively characterized by genomic and transcriptomic profiling and is represented in major cancer cell line resources.
Comprehensive quality control includes STR authentication, sterility testing (bacteria and fungi), and mycoplasma screening to ensure purity and performance. Genotype is confirmed by two rounds of PCR and Sanger sequencing, and complete validation reports are provided for make-to-order products.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?